| Immunotherapy for glioma: current management and future application S Xu, L Tang, X Li, F Fan, Z Liu Cancer letters 476, 1-12, 2020 | 528 | 2020 |
| The adaptive transition of glioblastoma stem cells and its implications on treatments Z Wang, H Zhang, S Xu, Z Liu, Q Cheng Signal transduction and targeted therapy 6 (1), 124, 2021 | 93 | 2021 |
| Inflammasome inhibitors: promising therapeutic approaches against cancer S Xu, X Li, Y Liu, Y Xia, R Chang, C Zhang Journal of hematology & oncology 12, 1-13, 2019 | 79 | 2019 |
| Expression of m6A regulators correlated with immune microenvironment predicts therapeutic efficacy and prognosis in gliomas S Xu, L Tang, G Dai, C Luo, Z Liu Frontiers in cell and developmental biology 8, 594112, 2020 | 67 | 2020 |
| Hypoxia-related lncRNA correlates with prognosis and immune microenvironment in lower-grade glioma S Xu, L Tang, Z Liu, C Luo, Q Cheng Frontiers in Immunology 12, 731048, 2021 | 44 | 2021 |
| CD74 correlated with malignancies and immune microenvironment in gliomas S Xu, X Li, L Tang, Z Liu, K Yang, Q Cheng Frontiers in molecular biosciences 8, 706949, 2021 | 32 | 2021 |
| Tumor treating fields for high-grade gliomas C Luo, S Xu, G Dai, Z Xiao, L Chen, Z Liu Biomedicine & Pharmacotherapy 127, 110193, 2020 | 25 | 2020 |
| Immune-related genes with APA in microenvironment indicate risk stratification and clinical prognosis in grade II/III gliomas S Xu, L Tang, G Dai, C Luo, Z Liu Molecular Therapy-Nucleic Acids 23, 1229-1242, 2021 | 21 | 2021 |
| Competing risk model to determine the prognostic factors and treatment strategies for elderly patients with glioblastoma Z Liu, S Feng, Y Zhang, L Zhang, S Xu, J Li, H Cao, J Huang, F Fan, ... Scientific reports 11 (1), 9321, 2021 | 17 | 2021 |
| circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling S Xu, C Luo, D Chen, L Tang, Q Cheng, L Chen, Z Liu Journal of Experimental & Clinical Cancer Research 42 (1), 64, 2023 | 13 | 2023 |
| Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma S Xu, C Luo, D Chen, L Tang, L Chen, Z Liu Cell Death & Disease 13 (8), 721, 2022 | 12 | 2022 |
| Bioinformatic analyses identify a prognostic autophagy-related long non-coding RNA signature associated with immune microenvironment in diffuse gliomas S Xu, L Tang, Z Liu, K Yang, Q Cheng Frontiers in Cell and Developmental Biology 9, 694633, 2021 | 11 | 2021 |
| Downregulation of CyclophilinA/CD147 axis induces cell apoptosis and inhibits glioma aggressiveness S Xu, C Hu, Z Xiao, C Luo, Z Liu BioMed Research International 2020 (1), 7035847, 2020 | 11 | 2020 |
| [Retracted] A Nanoparticle‐Conjugated Anti‐TBK1 siRNA Induces Autophagy‐Related Apoptosis and Enhances cGAS‐STING Pathway in GBM Cells S Xu, X Yan, L Tang, G Dai, C Luo Evidence‐Based Complementary and Alternative Medicine 2021 (1), 6521953, 2021 | 4 | 2021 |
| A novel mice model for studying the efficacy and IRAEs of Anti-CTLA4 targeted immunotherapy S Xu, X Yan, G Dai, C Luo Frontiers in Oncology 11, 692403, 2021 | 3 | 2021 |
| A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma S Xu, L Tang, G Dai, C Luo, Z Liu Clinical and Translational Medicine 10 (5), 2020 | 1 | 2020 |
| Mechanisms of reversal of temozolomide resistance in glioblastoma through downregulation of BCL3 by the Tumor Electric Field Therapy M Jia, Y Liu, Z Li, CK Luo, S Xu, HH Gong, J Wu, D Zhou, D Chen, ... | | 2023 |
